查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1468199

2024-2032 年按設備類型、治療類型、最終用戶和地區分類的人工胰腺設備系統市場報告

Artificial Pancreas Device Systems Market Report by Device Type, Treatment Type, End-User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球人工胰臟裝置系統（APDS）市場規模達23.385億美元。

APDS 是指閉迴路或自動胰島素輸送系統，透過調節胰島素的產生來管理血糖水平。它由連續血糖監測儀 (CGM)、皮下胰島素輸注幫浦和連接監測儀與幫浦的控制器組成。它運行一個複雜的演算法，根據即時血糖讀數的評估來確定適當的胰島素水平和輸送時間。它主要用於最大限度地降低體內葡萄糖水平極端波動的風險。

胰臟癌、胰臟炎和其他慢性疾病的盛行率不斷上升是推動市場成長的關鍵因素之一。此外，由於年齡相關因素、缺乏身體活動和不健康的飲食模式，糖尿病和肥胖症的發生率不斷增加，也促進了 APDS 在全球的廣泛採用。對高效糖尿病監測和微創（MI）給藥系統的需求不斷成長也推動了市場成長。 APDS 自動監測血糖值並全天以受控量注射胰島素。各種技術創新，包括與自動化控制整合的軟體為基礎的無線系統的開發，進一步促進了市場的成長。此外，各國監管機構和政府正大力投資研發（R&D），以改善全球醫療保健基礎設施。例如，美國食品藥品協會（US FDA）正在批准越來越多的新產品和創新產品，這為該國市場創造了積極的前景。

本報告回答的關鍵問題：

  • 迄今為止，全球人工胰臟設備系統市場表現如何，未來幾年將如何表現？
  • 主要區域市場有哪些？
  • COVID-19 對全球人工胰臟設備系統市場有何影響？
  • 根據設備類型分類的市場是怎麼樣的？
  • 根據治療類型的市場分類是怎樣的？
  • 基於最終用戶的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球人工胰臟設備系統市場的結構如何？
  • 產業競爭程度如何？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球人工胰臟設備系統市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依設備類型

  • 閾值暫停設備系統
    • 市場走向
    • 市場預測
  • 控制範圍系統
    • 市場走向
    • 市場預測
  • 控制目標系統
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依治療類型

  • 雙荷爾蒙
    • 市場走向
    • 市場預測
  • 僅胰島素
    • 市場走向
    • 市場預測
  • 混合
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 醫療中心
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格指標

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Beta Bionics Inc.
    • Bigfoot Biomedical Inc.
    • Dexcom Inc.
    • Inreda Diabetic BV
    • Insulet Corporation
    • Johnson & Johnson
    • Medtronic Inc.
    • F. Hoffmann-La Roche Ltd
    • Tandem Diabetes Care Inc.
Product Code: SR112024A1918

The global artificial pancreas device systems (APDS) market size reached US$ 2,338.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 5,800.2 Million by 2032, exhibiting a growth rate (CAGR) of 10.3% during 2024-2032.

APDS refers to a closed-loop or automated insulin delivery system that manages blood glucose levels by regulating the production of insulin. It consists of a continuous glucose monitor (CGM), a subcutaneous insulin infusion pump and a controller that links the monitor with the pump. It runs a complex algorithm that determines the adequate levels of insulin and time of delivery based on the evaluation of real-time glucose readings. It is primarily used to minimize the risks of extreme fluctuations of glucose levels in the body.

The increasing prevalence of pancreatic cancer, pancreatitis and other chronic ailments is one of the key factors driving the growth of the market. Furthermore, the growing occurrence of diabetes and obesity, due to age-related factors, physical inactivity and unhealthy dietary patterns, is also contributing to the widespread adoption of APDS across the globe. The rising demand for efficient diabetes monitoring and minimally invasive (MI) drug delivery systems is also providing a boost to the market growth. APDS automatically monitors the glucose levels and administers doses of insulin throughout the day in controlled amounts. Various technological innovations, including the development of software-based wireless systems that are integrated with automated controls, are further contributing to the market growth. Moreover, regulatory bodies and governments of various nations are significantly investing in research and development (R&D) for the improvement of healthcare infrastructure across the globe. For instance, the Food and Drug Association (US FDA) in the United States is approving an increasing number of new and innovative products, which is creating a positive outlook for the market in the country.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial pancreas device systems (APDS) market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on device type, treatment type and end-user.

Breakup by Device Type:

Threshold Suspend Device Systems

Control-to-Range Systems

Control-to-Target Systems

Breakup by Treatment Type:

Bi-hormonal

Insulin Only

Hybrid

Breakup by End-User:

Hospitals

Medical Centres

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Beta Bionics Inc., Bigfoot Biomedical Inc., Dexcom Inc., Inreda Diabetic B.V., Insulet Corporation, Johnson & Johnson, Medtronic Inc., F. Hoffmann-La Roche Ltd, Tandem Diabetes Care Inc., etc.

Key Questions Answered in This Report:

  • How has the global artificial pancreas device systems market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global artificial pancreas device systems market?
  • What is the breakup of the market based on the device type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global artificial pancreas device systems market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Artificial Pancreas Device Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Device Type

  • 6.1 Threshold Suspend Device Systems
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Control-to-Range Systems
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Control-to-Target Systems
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Bi-hormonal
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Insulin Only
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Hybrid
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Medical Centres
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Beta Bionics Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Bigfoot Biomedical Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Dexcom Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Inreda Diabetic B.V.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Insulet Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Johnson & Johnson
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Medtronic Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 F. Hoffmann-La Roche Ltd
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Tandem Diabetes Care Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials

List of Figures

  • Figure 1: Global: Artificial Pancreas Device Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Artificial Pancreas Device Systems Market: Breakup by Device Type (in %), 2023
  • Figure 4: Global: Artificial Pancreas Device Systems Market: Breakup by Treatment Type (in %), 2023
  • Figure 5: Global: Artificial Pancreas Device Systems Market: Breakup by End-User (in %), 2023
  • Figure 6: Global: Artificial Pancreas Device Systems Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 8: Global: Artificial Pancreas Device Systems (Threshold Suspend Device Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Artificial Pancreas Device Systems (Threshold Suspend Device Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Artificial Pancreas Device Systems (Control-to-Range Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Artificial Pancreas Device Systems (Control-to-Range Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Artificial Pancreas Device Systems (Control-to-Target Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Artificial Pancreas Device Systems (Control-to-Target Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Artificial Pancreas Device Systems (Bi-hormonal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Artificial Pancreas Device Systems (Bi-hormonal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Artificial Pancreas Device Systems (Insulin Only) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Artificial Pancreas Device Systems (Insulin Only) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Artificial Pancreas Device Systems (Hybrid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Artificial Pancreas Device Systems (Hybrid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Artificial Pancreas Device Systems (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Artificial Pancreas Device Systems (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Artificial Pancreas Device Systems (Medical Centres) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Artificial Pancreas Device Systems (Medical Centres) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Artificial Pancreas Device Systems (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Artificial Pancreas Device Systems (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia Pacific: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia Pacific: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Global: Artificial Pancreas Device Systems Industry: SWOT Analysis
  • Figure 75: Global: Artificial Pancreas Device Systems Industry: Value Chain Analysis
  • Figure 76: Global: Artificial Pancreas Device Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Artificial Pancreas Device Systems Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Device Type (in Million US$), 2024-2032
  • Table 3: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
  • Table 4: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 5: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Artificial Pancreas Device Systems Market: Competitive Structure
  • Table 7: Global: Artificial Pancreas Device Systems Market: Key Players